Moreira MV

ORCID: 0000-0002-5558-8337 · 4 papers in corpus
2026
Follicular fluid from women with polycystic ovary syndrome induces granulosa cells metabolic dysfunction that is exacerbated by obesity.
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1783780

BackgroundPolycystic ovary syndrome (PCOS) is characterized by altered follicular development and metabolic dysfunction, frequently exacerbated by obesity. The follicular fluid (FF) microenvironment plays a critical role in supporting oocyt…

2025
Polycystic ovary syndrome and excessive body weight impact independently and synergically on fertility treatment outcomes.
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-025-01434-8

BackgroundPolycystic ovary syndrome (PCOS) and obesity can both disrupt reproductive function. However, the extent to which obesity contributes to PCOS manifestations is not very clear. This study aimed to disentangle the relative contribut…

2024
Anti-Müllerian hormone a surrogate of follicular fluid oxidative stress in polycystic ovary syndrome?
Frontiers in cell and developmental biology ·doi:10.3389/fcell.2024.1408879

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women at childbearing age. Anti-Müllerian hormone (AMH) is a widely accepted sensitive marker of ovarian reserve, which has been suggested that could also act as biomarke…

2023
Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: A systematic review.
Reviews in endocrine & metabolic disorders ·doi:10.1007/s11154-023-09819-z

Polycystic ovary syndrome (PCOS) is recognized as one of the most prevalent endocrinopathy in women at reproductive age. As affected women tend to have poorer assisted reproductive technology (ART) outcomes, PCOS has been suggested to endan…